Sofinnova Investments, Inc. Tg Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,861,277 shares of TGTX stock, worth $41 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
1,861,277
Previous 1,984,962
6.23%
Holding current value
$41 Million
Previous $30.2 Million
9.68%
% of portfolio
1.84%
Previous 1.76%
Shares
12 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$302 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$251 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$148 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$80.3 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$71.5 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.2B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...